STOCK TITAN

Fortrea (FTRE) Form 144 Notice — 1,677 Restricted Shares for Sale

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Fortrea Holdings Inc. (FTRE) filed a Form 144 to notify a proposed sale of common stock. The filer plans to sell 1,677 shares through Fidelity Brokerage Services with an aggregate market value of $17,154.20, representing part of 90,800,000 shares outstanding. The approximate sale date is 09/09/2025. The shares were acquired on 09/08/2025 through restricted stock vesting from the issuer and the payment is described as compensation. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

Positive

  • Shares were acquired via restricted stock vesting, indicating compensation rather than an open-market purchase
  • Form 144 filed with broker identified as Fidelity Brokerage Services, showing a standard, regulated execution channel
  • Filer attests to no undisclosed material adverse information about the issuer

Negative

  • None.

Insights

TL;DR: Small executive/insider sale from recent restricted stock vesting; immaterial to FTRE capitalization.

The Form 144 documents a planned sale of 1,677 common shares with an aggregate market value of $17,154.20 through Fidelity, scheduled for 09/09/2025. The shares were acquired one day earlier via restricted stock vesting and tied to compensation. Relative to 90.8 million shares outstanding, this sale is de minimis and unlikely to affect share supply or market price. The filing follows Rule 144 notification requirements and includes the representative attestation regarding undisclosed material information.

TL;DR: Routine insider sale following vesting; standard disclosure and attestation included.

The notice indicates a beneficiary sold shares received from restricted stock vesting, using Fidelity Brokerage Services as the broker. The filer provides the standard attestation about lacking undisclosed material adverse information. There are no disclosures of prior sales in the past three months and no indications of unusual trading arrangements. From a governance standpoint, this is a routine compensation-related sale with standard compliance signals.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Fortrea Holdings Inc.'s (FTRE) Form 144 report?

The filing reports a proposed sale of 1,677 common shares with aggregate market value of $17,154.20, through Fidelity Brokerage Services, approximately on 09/09/2025.

How were the FTRE shares acquired that are being sold?

The shares were acquired on 09/08/2025 via restricted stock vesting from the issuer and the payment is described as compensation.

What broker will handle the FTRE sale disclosed in Form 144?

Fidelity Brokerage Services LLC at the address listed in the filing is named as the broker for the proposed sale.

How many FTRE shares are outstanding per the filing?

The filing lists 90,800,000 shares outstanding for the issuer.

Does the filer report any securities sold in the past three months?

No; the filing states "Nothing to Report" for securities sold during the past three months.
Fortrea Holdings

NASDAQ:FTRE

FTRE Rankings

FTRE Latest News

FTRE Latest SEC Filings

FTRE Stock Data

1.64B
91.87M
0.5%
111.46%
11.57%
Biotechnology
Services-medical Laboratories
Link
United States
DURHAM